We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
+7.69%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$508M
AUM Growth
+$11.3M
Cap. Flow
+$5.18M
Cap. Flow %
1.02%
Top 10 Hldgs %
26.12%
Holding
122
New
10
Increased
33
Reduced
37
Closed
13

Top Buys

Rank Stock Value
1
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$6.03M
2
CINC
CinCor Pharma, Inc. Common Stock
CINC
+$5.53M
3
SPRY icon
ARS Pharmaceuticals
SPRY
+$5.15M
4
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$5.12M
5
IRTC icon
iRhythm Holdings
IRTC
+$4.03M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$9.2M
2
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$6.77M
3
TNDM icon
Tandem Diabetes Care
TNDM
+$6.26M
4
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$4.85M
5
CNVY
Convey Health Solutions Holdings, Inc.
CNVY
+$4.16M

Sector Composition

Rank Sector Weight
1 Healthcare 95.94%
2 Industrials 4.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BLU
26
DELISTED
BELLUS Health Inc.
BLU
$6.49M 1.28%
614,429
+113,016
+23% +$1.2M
CINC
27
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
$6.42M 1.26%
+195,534
New +$5.53M
TVTX icon
28
Travere Therapeutics
TVTX
$5.2B
$6.15M 1.21%
249,700
+17,700
+8% +$457K
RXDX
29
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$6.09M 1.2%
103,210
-69,295
-40% -$3.17M
FOLD
30
DELISTED
Amicus Therapeutics
FOLD
$5.98M 1.18%
572,682
+11,800
+2% +$131K
LLY icon
31
Eli Lilly
LLY
$1.02T
$5.95M 1.17%
18,415
– –
RCUS icon
32
Arcus Biosciences
RCUS
$3.55B
$5.94M 1.17%
227,032
-84,750
-27% -$2.24M
HZNP
33
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$5.85M 1.15%
94,450
+44,625
+90% +$3.12M
AMLX icon
34
Amylyx Pharmaceuticals
AMLX
$2.26B
$5.78M 1.14%
+205,400
New +$5.12M
ITCI
35
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$5.7M 1.12%
122,450
+31,650
+35% +$1.65M
PFE icon
36
Pfizer
PFE
$143B
$5.66M 1.12%
129,400
– –
CTIC
37
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$5.64M 1.11%
+968,300
New +$6.03M
SPRY icon
38
ARS Pharmaceuticals
SPRY
$509M
$5.52M 1.09%
+1,045,234
New +$5.15M
HALO icon
39
Halozyme
HALO
$9.79B
$5.43M 1.07%
137,400
+7,000
+5% +$309K
HUM icon
40
Humana
HUM
$43.7B
$5.4M 1.06%
11,125
-3,100
-22% -$1.51M
TMCI icon
41
Treace Medical Concepts
TMCI
$280M
$5.38M 1.06%
243,674
-133,004
-35% -$2.57M
THC icon
42
Tenet Healthcare
THC
$20.5B
$5.24M 1.03%
101,500
– –
ALKS icon
43
Alkermes
ALKS
$8.22B
$5.19M 1.02%
232,400
+42,750
+23% +$1.11M
SILK
44
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$5.13M 1.01%
114,000
-112,764
-50% -$4.85M
ABT icon
45
Abbott
ABT
$183B
$5.01M 0.99%
51,748
-5,000
-9% -$533K
MRK icon
46
Merck
MRK
$322B
$4.97M 0.98%
57,750
– –
BSX icon
47
Boston Scientific
BSX
$69.5B
$4.92M 0.97%
126,976
– –
BMY icon
48
Bristol-Myers Squibb
BMY
$133B
$4.66M 0.92%
65,500
+29,000
+79% +$2.1M
ALNY icon
49
Alnylam Pharmaceuticals
ALNY
$27.5B
$4.54M 0.89%
22,680
+10,650
+89% +$2.03M
STAA icon
50
STAAR Surgical
STAA
$1.21B
$4.41M 0.87%
62,500
– –
1
2
3 4 5

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q3 2022 Portfolio in Review

As of Q3 2022, Sectoral Asset Management held 122 positions worth $508M, up 2.3% from $496M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Sectoral Asset Management's Q3 2022 filing shows 10 new, 33 increased, 37 reduced and 13 closed positions. Its largest new stake was CTI BioPharma Corp. (DE) Common Stock: 968,300 shares worth $5.64M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $9.2M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 96% a quarter earlier, followed by Industrials.

  • Sectoral Asset Management's largest Q3 2022 buy was CTI BioPharma Corp. (DE) Common Stock: 968,300 shares worth $5.64M.
  • Sectoral Asset Management added most to iRhythm Holdings in Q3 2022, an estimated $4.03M increase.
  • Sectoral Asset Management's biggest Q3 2022 reduction was Silk Road Medical, Inc. Common Stock, cutting an estimated $4.85M.
  • Sectoral Asset Management fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $9.2M.
  • Sectoral Asset Management's ten largest holdings make up 26% of its $508M portfolio in Q3 2022.
  • Sectoral Asset Management opened 10 new positions and closed 13 in Q3 2022.
  • Sectoral Asset Management's portfolio value rose 2.3% quarter-over-quarter to $508M.

Based on Sectoral Asset Management's 13F filing for Q3 2022, filed 10 Nov 2022.